Dyslipidemia Mixed

• FDA approval · 2023-03-24
  FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for fenofibrate submitted by Mylan Pharmaceuticals Inc., for a generic fenofibrate product.

• FDA approval · 2017-09-18
  FDA Approved: GEMFIBROZIL — Supplemental Application (NorthStar Rx LLC)

  FDA approved a supplemental ANDA for Gemfibrozil from NorthStar Rx LLC, confirming regulatory approval of a generic Gemfibrozil product.